Resources

This document highlights the potential of intradermal vaccine delivery to improve vaccine equity through dose sparing, simplified administration, and expanded access. Learn about emerging ID injection technologies such as: autodisable ID needle and syringe, disposable-syringe jet injectors, and syringe-based hollow microneedle devices. Includes an overview of PATH’s work to assess the value, feasibility, and adoption of these innovations in low- and middle-income countries.

The Financial Advisory Strategy Taskforce (FAST), led by PATH with support from Coefficient Giving and GiveWell, is a multi-country initiative to provide targeted technical assistance to ministries of health to respond to funding disruptions. The program aims to equip countries with data-driven insights to optimize existing funding and commodity flows for maximum impact, along with providing strategic planning tools and technical support to respond to the acute funding crisis.This fact sheet describes the FAST initiative in the Democratic Republic of the Congo (DRC), where it supports the Ministry of Health in responding to funding reductions through evidence-based planning and strategic resource allocation. It highlights the project's key priority areas, core objectives, and major achievements to date.Learn more about FAST here.

The Financial Advisory Strategy Taskforce (FAST), led by PATH with support from Coefficient Giving and GiveWell, is a multi-country initiative to provide targeted technical assistance to ministries of health to respond to funding disruptions. The program aims to equip countries with data-driven insights to optimize existing funding and commodity flows for maximum impact, along with providing strategic planning tools and technical support to respond to the acute funding crisis.This fact sheet describes the FAST initiative in Mozambique, where it supports the Ministry of Health in responding to funding reductions through evidence-based planning and strategic resource allocation. It highlights the project's key priority areas, core objectives, and major achievements to date.Available in English and Portuguese.Learn more about FAST here.

On July 30, 2026, PATH held a webinar on innovative approaches to building demand for malaria vaccines through community engagement. Speakers highlighted early insights and lessons learned, with a focus on driving uptake of all four doses.Featured speakers included:Cindy Bergstrom, World Health OrganizationMarie Nzita Ndambi, National Health Communication Program, Kongo Central Province, Democratic Republic of the CongoEleonora Genovese, Gavi, the Vaccine AllianceThis was the third instance in a quarterly webinar series this year on learnings from malaria vaccine rollout in Africa. Explore resources from all of PATH's malaria vaccine webinars here.

This slide provides a snapshot of the Group B Streptococcus (GBS) vaccine technology landscape, in the effort to track the development of GBS vaccine candidates and provide a summary of the various vaccine approaches being worked on around the world.This snapshot pairs with the GBS Vaccine Clinical Trial Tracker, which provides publicly available information on clinical trials of GBS vaccine candidates intended for disease prevention.To share any updates or corrections to the snapshot, please contact gbssnapshot@path.org.